China Spinal Surgery Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 3.10 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
China Spinal Surgery Devices Market Analysis
The China spinal surgery devices market is expected to register a CAGR of 3.1% over the forecast period.
The outbreak of the COVID-19 pandemic has pushed the medical device industry into action, with a race to develop both therapeutic and preventive devices in China. Exponentially increasing cases of the coronavirus in China are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the manufacturers of medical devices were highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. The outbreak of the pandemic adversely impacted the market in China. Most spine surgeons suffered from COVID-19 owing to which the majority of the surgical procedures were delayed or canceled. For instance, as per the study titled, "Safe Spine Surgery During the COVID-19 Pandemic" published in April 2021, the rates of COVID-19 infection among orthopedic surgeons in China were as high as 20.0%. However, increasing cases of obesity during lockdown postively impacted the market, as obesity is one of the major factors for triggering the degenerative spinal conditions. For instance, as per the study titled, "Obesity and activity patterns before and during COVID-19 lockdown among youths in China" published in October 2020, prior to COVID-19, the mean body mass index (BMI) of all youths was 21.8 kg/m2, with the prevalence of overweight/obesity and obesity being 21.3% and 10.5%, respectively. But within the month of COVID-19 lockdown, BMI has significantly increased in overall youths and the prevalence of overweight/obesity has significantly increased in China. Therefore, such instances indicate that the market witnessed a moderate growth during the pandemic.
The increasing Incidences of obesity, diabetes, and degenerative spinal conditions and increasing adoption rate of minimally invasive spinal surgeries are the major factors driving the market growth over the forecast period. For instance, according to the report published by the International Diabetes Federation in November 2021, around 140,869.6 people are living with diabetes in China age groups ranging from 20 to 79 years. It also reported that the prevalence rate of diabetes in China was around 10.6% in 2021, whereas in 2011 it was around 8.8%. Furthermore, it also reported that around 72,839.5 people were living with undiagnosed diabetes in 2021. The people living with diabetes are of greater risk of developing painful disc degeneration in the lower back. Thus, increasing cases of diabetes may increase the cases of the spinal disorders. Furthermore, as per the study titled, "Prevalence, Incidence, and External Causes of Traumatic Spinal Cord Injury in China: A Nationally Representative Cross-Sectional Survey" published in January 2022, It is estimated that around 759,302 prevalent patients with traumatic spinal cord injury and 66,374 new traumatic spinal cord injury cases were detected annually in China. Therefore, such instances are anticipated to propel the demand of spinal surgery devices in China, thereby boosting the market growth over the forecast period.
However, expensive treatment procedures is anticipated to hinder the market growth over the forecast period.
China Spinal Surgery Devices Market Trends
This section covers the major market trends shaping the China Spinal Surgery Devices Market according to our research experts:
Arthroplasty Devices is Expected to Witness Growth Over the Forecast Period
Arthroplasty is a surgical procedure used to restore joint function. The joint can be restored by resurfacing the bones. Arthroplasty, also known as total disc replacement, is a minimally invasive spine surgery used to treat damaged and degenerated spinal discs. At the time of the procedure, the degenerated disc is removed and replaced with an artificial disc. Many factors can lead to disc degeneration that requires surgical repair such as age, traumatic accidents, normal tear, and wear, and genetics.
The increasing cases of spinal disorders and accident cases are the major drivers of the segment's growth. For instance, according to an article published by Zhi-Meng Wang, Peng Zou, and Jun-Song Yang in 2020, the primary cause of spinal cord injuries in the country is 47.75% from low falls, 37.31% from high falls, followed by traffic accidents with 8.98%. Furthermore, increasing cases of traumatic spinal cord injury (TSCI) in China is also influencing the segment growth. For instance, according to the study titled, "Epidemiological features of traumatic spinal cord injury in Guangdong Province, China" published in March 2020, traumatic spinal cord injury is considered to be the second cause after traumatic brain injury in terms of morbidity and disability in China. It also stated that the number of traumatic spinal cord injury patients is extimated to be quiet large and also demonstrated a rising trend. Therefore, such instances, indicate that the segment is anticipated to witness considerable growth over the forecast period.
China Spinal Surgery Devices Industry Overview
The market is consolidated and consists of a few major players. Moreover, with the increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Stryker Corporation, Johnson & Johnson, Zimmer Holdings Inc., Chunlizhengda Medical Instruments Co, and Medtronic PLC among others.
China Spinal Surgery Devices Market Leaders
-
Styker Corporation
-
Johnson & Johnson
-
Medtronic Plc
-
Beijing Fule
-
Zimmer Holdings Inc.
*Disclaimer: Major Players sorted in no particular order
China Spinal Surgery Devices Market News
- In July 2022, German-based joimax deals with technologies and training methods for full-endoscopic and minimally invasive spinal surgery partnered with Andeller (Nanjing) Healthcare and Technology Co., Ltd., a subsidiary of C&D Corp. Ltd to distribute full-endoscopic and minimally invasive spinal surgery devices in China.
- In June 2022, Implanet announced a commercial, technological and financial partnership with Sanyou Medical, a chinese manufacturer of medical devices for spine surgery. The agreement was signed to to distribute Implanet's JAZZ platform in China.
China Spinal Surgery Devices Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Defination
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Obesity, Diabetes, and Degenerative Spinal Conditions
4.2.2 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.3 Market Restraints
4.3.1 High Cost of Sophisticated Endoscopy Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Others
5.1.2 Spinal Fusion
5.1.2.1 Cervical Fusion
5.1.2.2 Interbody Fusion
5.1.2.3 Other Spinal Fusions
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Styker Corporation
6.1.2 Johnson & Johnson
6.1.3 Zimmer Holdings Inc.
6.1.4 Chunlizhengda Medical Instruments Co
6.1.5 Beijing Fule
6.1.6 Medtronic PLC
6.1.7 Orthofix Holdings Inc.
6.1.8 Globus Medical, Inc.
6.1.9 B. Braun Melsungen AG
6.1.10 Seaspine Holdings Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
China Spinal Surgery Devices Industry Segmentation
As per the scope of the report, spinal surgery devices are devices used for the treatment of spinal injuries or deformities. They help restructure or realign the spine. The China Spinal Surgery Devices Market is Segmented by Device Type (Spinal Decompression (Corpectomy, Discectomy, Others), Spinal Fusion (Cervical Fusion, Interbody Fusion, Other Spinal Fusions), Fracture Repair Devices, Arthroplasty Devices, and Non-fusion Devices)). The report offers the value (in USD million) for the above segments.
| By Device Type | |||||
| |||||
| |||||
| Fracture Repair Devices | |||||
| Arthroplasty Devices | |||||
| Non-fusion Devices |
China Spinal Surgery Devices Market Research FAQs
What is the current China Spinal Surgery Devices Market size?
The China Spinal Surgery Devices Market is projected to register a CAGR of 3.10% during the forecast period (2024-2029)
Who are the key players in China Spinal Surgery Devices Market?
Styker Corporation, Johnson & Johnson, Medtronic Plc, Beijing Fule and Zimmer Holdings Inc. are the major companies operating in the China Spinal Surgery Devices Market.
What years does this China Spinal Surgery Devices Market cover?
The report covers the China Spinal Surgery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Spinal Surgery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
China Spinal Surgery Devices Industry Report
Statistics for the 2024 China Spinal Surgery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Spinal Surgery Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
